A Supreme Court ruling gives drug companies more leeway to conduct research using patented substances from competitors.
Justices today unanimously reversed a lower court ruling in favor of a patent-holder (Integra LifeSciences Holdings Corporation).
It means big drug companies have more flexibility to start experimenting with potential therapies as long as they won't be marketed until a competitor's patent expires.
The patent-holder had accused a German company of infringing on a patent on certain molecules. Researchers hope the patented biological molecules can inhibit tumors.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or firstname.lastname@example.org.